Susan Swetter, M.D.
Academic Appointments
- Professor - Med Center Line, Dermatology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Stanford Comprehensive Cancer Center 875 Blake Wilbur Dr Clinic A MC 5820 Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 723-6956Pigmented Lesion and Melanoma Clinic 875 Blake Wilbur Dr Clinic A Stanford, CA 94305 Tel Work (650) 498-6000 Fax (650) 721-2521
- Academic Offices
Personal Information Email Tel (650) 852-3494Alternate Contact Heather Teague Administrative Officer, VAPAHCS Dermatology Email Tel Work 650-852-3494Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Cutaneous (Dermatologic) Oncology
- Pigmented Skin Lesions
- Melanoma
- Skin Cancer
- Basal/ Squamous Cell Carcinomas - VA Dermatology
- Dermatology
Administrative Appointments
- Medical Advisory Panel, Melanoma Research Alliance (2013 - present)
- Physician Leader, Stanford Cancer Care Program in Cutaneous Oncology (2012 - present)
- President, Board of Directors, American Cancer Society, Santa Clara County Unit (2009 - 2011)
- Member, Melanoma Panel, National Comprehensive Cancer Network (2007 - present)
- Member, Board of Directors, American Cancer Society, Santa Clara County Unit (2007 - present)
- Member, Melanoma Clinical Guidelines Task Force, American Academy of Dermatology (2006 - 2012)
Honors and Awards
- Humanitarian Award Recipient, Melanoma Research Foundation (2012)
- Member, American Dermatological Association (2011)
- Leadership Award, Melanoma Care Coalition (2007)
- PresidentÂ’s Volunteer Service Award, PresidentÂ’s Council on Service & Civic Participation, Corporation for National & Community Service (2007)
- Recognition for Excellence in Teaching, Stanford University School of Medicine (2004, 2009)
- Nominated, Franklin G. Ebaugh, Jr. Award (outstanding dedication to advising medical students), Stanford University School of Medicine (1999, 2001, 2004, 2009)
Professional Education
| Residency: | Stanford University School of Medicine CA (1994) |
| Board Certification: | Dermatology, American Board of Dermatology (1994) |
| Internship: | UCSF Medical Center, CA USA (1991) |
| Medical Education: | University of Pennsylvania School of Medicine PA (1990) |
| BA: | University of Virginia, Interdisciplinary Studies (1986) |
| MD: | University of Pennsylvania, Medicine (1990) |
Graduate & Fellowship Program Affiliations
Community and International Work
- President, Board of Directors, American Cancer Society Santa Clara County Unit, Campbell, CA
- Program Director, Stanford Skin Cancer Screening Program, 1995-2011, Stanford Medicine Outpatient Clinics
Internet Links
Scientific Focus
Current Research Interests
Dr. Swetter has directed the Pigmented Lesion and Melanoma Programs at Stanford University Medical Center and Cancer Center and VA Palo Alto since 1995. She serves as the national dermatology liaison to the Eastern Cooperative Oncology Group (ECOG) Melanoma Committee and Co-Chairs the Melanoma Prevention Working Group, a national forum for research collaboration among academic oncologists, dermatologists, epidemiologists, and surgeons dedicated to cancer control and prevention, and currently comprised of 29 Intergroup (ECOG, SWOG, CALGB) melanoma centers in the US. Dr. Swetter's research interests include secondary prevention of melanoma, including early detection and screening of high-risk groups, melanoma chemoprevention in individuals with atypical mole syndrome, and research focused on increasing professional and public education to improve melanoma awareness. She is also engaged in clinical studies of the epidemiology, prognostic factors, and therapy of melanoma and nonmelanoma skin cancers.
Clinical Trials
- Recruiting A Study of Vemurafenib Adjuvant Therapy in Patients With Resected Cutaneous BRAF Mutant Melanoma
- Recruiting Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
- Recruiting Study of the Safety and Pharmacokinetics of MPDL3280A Administered Intravenously As a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
- Not Recruiting Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
- Recruiting Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy
Publications
- Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: The Women's Health Initiative. Cancer. 2013; (8): 1562-9
- Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013; (4): 395-407
- A systemic complete response of metastatic melanoma to local radiation and immunotherapy. Transl Oncol. 2012; (6): 404-7
- Attitudes toward indoor tanning among users of sunless tanning products. Arch Dermatol. 2012; (1): 124-6
- Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012; (15): 3725-34
- Examining the pathways linking lower socioeconomic status and advanced melanoma. Cancer. 2012; (16): 4004-13
Help